Related Experiment Video
Updated: Jun 18, 2026

Analysis of Transforming Growth Factor ß Family Cleavage Products Secreted Into the Blastocoele of Xenopus laevis Embryos
Published on: July 21, 2021
Enzymatic processing of beta-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site
Manuela Bozzi1, Rosanna Inzitari, Diego Sbardell
1Istituto di Biochimica e Biochimica Clinica, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, Rome, Italy.
Abstract:
Dystroglycan (DG) is a membrane receptor belonging to the complex of glycoproteins associated to dystrophin. DG is formed by two subunits, alpha-DG, a highly glycosylated extracellular matrix protein, and beta-DG, a transmembrane protein. The two DG subunits interact through the C-terminal domain of alpha-DG and the N-terminal extracellular domain of beta-DG in a noncovalent way. Such interaction is crucial to maintain the integrity of the plasma membrane. In some pathological conditions, the interaction between the two DG subunits may be disrupted by the proteolytic activity of gelatinases (i.e. MMP-9 and/or MMP-2) that removes a portion or the whole beta-DG ectodomain producing a 30 kDa truncated form of beta-DG. However, the molecular mechanism underlying this event is still unknown. In this study, we carried out proteolysis of the recombinant extracellular domain of beta-DG, beta-DG(654-750) with human MMP-9, characterizing the catalytic parameters of its cleavage. Furthermore, using a combined approach based on SDS-PAGE, MALDI-TOF and HPLC-ESI-IT mass spectrometry, we were able to identify one main MMP-9 cleavage site that is localized between the amino acids His-715 and Leu-716 of beta-DG, and we analysed the proteolytic fragments of beta-DG(654-750) produced by MMP-9 enzymatic activity.
Insights
Matrix metalloproteinase-9 (MMP-9) cleaves beta-dystroglycan (beta-DG) at a specific site, disrupting the dystroglycan complex. This cleavage, occurring between His-715 and Leu-716, generates a truncated beta-DG form, impacting plasma membrane integrity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Dystroglycan (DG) is a crucial membrane receptor complex essential for plasma membrane integrity.
- DG consists of alpha-DG and beta-DG subunits, whose noncovalent interaction is vital.
- Proteolytic cleavage by gelatinases, like MMP-9, can disrupt this interaction, leading to pathological conditions.
Purpose of the Study:
- To investigate the molecular mechanism by which MMP-9 cleaves beta-dystroglycan.
- To characterize the catalytic parameters of MMP-9 cleavage on beta-DG.
- To identify the specific cleavage site and analyze the resulting proteolytic fragments.
Main Methods:
- Proteolysis of recombinant beta-DG extracellular domain (beta-DG(654-750)) using human MMP-9.
- Characterization of enzymatic cleavage parameters.
- Analysis of proteolytic fragments using SDS-PAGE, MALDI-TOF, and HPLC-ESI-IT mass spectrometry.
Main Results:
- Identified a primary MMP-9 cleavage site on beta-DG located between His-715 and Leu-716.
- Characterized the catalytic parameters of MMP-9-mediated beta-DG cleavage.
- Analyzed the resulting proteolytic fragments of beta-DG(654-750).
Conclusions:
- MMP-9 specifically cleaves beta-dystroglycan at the His-715/Leu-716 site.
- This cleavage event contributes to the generation of truncated beta-DG forms.
- Understanding this mechanism is key to addressing pathological conditions involving DG complex disruption.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Export of Misfolded Proteins out of the ER
